Physician profile
Matthew D Smith
NPI 1871054734
$3,011.56
in general payments reported to CMS, 2019-2025
33 companies · $906 in 2025
The $906 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.98 · 2022: $207 · 2023: $878 · 2024: $999 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,782.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $615.67 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $517.27 | 2023-2025 | Vraylar, Linzess, Ubrelvy |
| Pfizer INC. | $488.12 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $233.31 | 2023-2025 | |
| Lilly USA, LLC | $90.87 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Edwards Lifesciences Corporation | $89.73 | 2024-2025 | |
| Boston Scientific Corporation | $81.52 | 2024-2025 | Wavewriter Alpha Prime 16, General - Female Sui |
| Astellas Pharma US INC | $71.84 | 2023-2025 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $63.83 | 2022-2024 | |
| Amgen INC. | $63.66 | 2022-2025 | Repatha, Otezla, Krystexxa |
| E.R. Squibb & Sons, L.L.C. | $62.56 | 2022-2025 | Eliquis, Camzyos |
| Sumitomo Pharma America, INC. | $56.88 | 2023 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $55.92 | 2022-2023 | Keveyis |
| Heartflow, INC. | $46.73 | 2025 | |
| Medline Industries LP | $37.90 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $37.37 | 2023-2024 | Rexulti |
| Inspire Medical Systems, INC. | $37.10 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $35.78 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Phathom Pharmaceuticals, INC. | $35.09 | 2023-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.46 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $31.27 | 2022-2023 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Medtronic, INC. | $30.34 | 2024-2025 | Intellis Adaptivestim, Minimed 780g |
| Kci USA, INC. | $25.71 | 2023 | Prevena, V.A.C. Veraflo |
| Sanofi Pasteur INC. | $22.18 | 2025 | |
| Gilead Sciences, INC. | $21.98 | 2021 | |
| Nevro Corp. | $19.88 | 2023 | Senza |
| Philips North America LLC | $18.67 | 2024 | (Ck7) Extended Holter |
| Astrazeneca Pharmaceuticals LP | $16.96 | 2024 | Airsupra |
| Lundbeck LLC | $16.29 | 2024 | Vyepti |
| Daiichi Sankyo INC. | $16.21 | 2023 | Injectafer |
| Horizon Therapeutics Plc | $15.65 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.66 | 2022 | |
| Daxor Corporation | $8.15 | 2023 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.